[an error occurred while processing this directive]
2005 Indiana Report of Infectious Diseases |
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
*Rate per 100,000 population based on the U.S. Census Bureau’s population data as of July 1, 2005 |
|||||||||||||||||||||||||||||||||||||||||||||||
Haemophilus influenzae is a gram-negative coccobacillus having two forms, a nonencapsulated and an encapsulated form. The encapsulated form is typeable and has been classified as serotypes a through f. Humans are the natural host with up to 80 percent of healthy individuals colonized with the nontypeable form.
Prior to the licensure of H. influenzae type b vaccine, H. influenzae type b (Hib) disease was the leading cause of bacterial meningitis in children. Since the introduction of conjugate Hib vaccine in 1990, the incidence of Hib disease in children has decreased dramatically in both the U.S. and Indiana. Invasive disease caused by H. influenzae type b and other serotypes can affect many organ systems. The most common types of invasive disease are bacteremia/sepsis, meningitis, epiglottitis, pneumonia, arthritis, and cellulitis. All invasive H. influenzae disease, regardless of age or serotype, is reportable in Indiana. Figure 1 shows the total number of Haemophilus influenzae cases reported by year for 2001-2005.
Indiana had 71 reported cases of invasive H. influenzae (all
serotypes) disease in 2005 (Table 1). Disease incidence was lowest during the
summer and fall months with the greatest incidence in spring (Figure
2). Age-specific rates were greatest for older adults aged 80+ years of age
(7.02) and for infants under the age of 1 year (6.97).
Figure 3 shows H. influenzae
incidence by age group. Females (1.16) were slightly more likely than males
(1.10) to become ill with H. influenzae. The rate for blacks (1.80) was
almost twice as high as that for whites (0.92).
Although 31 counties reported cases of H. influenzae, only Marion (16)
and Elkhart (5) had 5 or more cases (Figure
4).
Of the 71 reported cases in 2005, 51 (72%) were serotyped. Table 2 presents a breakdown of cases by serotype.
| Percent of Reported Cases by Serotype | ||
|---|---|---|
| Type | Number | Percent |
| a | 0 | 0 |
| b | 0 | 0 |
| c | 0 | 0 |
| d | 1 | 1.5 |
| e | 1 | 1.5 |
| f | 10 | 14.0 |
| Nontypeable | 39 | 55.0 |
| Not Tested/Unknown | 20 | 28.0 |
| Total | 71 | |
| Source: Indiana State Department of Health | ||
Because Hib vaccines protect against type b and no other strains of H. influenzae, serotyping of all H. influenzae isolates from patients (especially from those under age 5) with invasive disease is necessary to monitor vaccination program effectiveness and national progress towards Hib elimination. Serotype information is also needed to measure the sensitivity of the surveillance system and to detect the emergence of invasive disease from nontype b H. influenzae strains.
You can learn more about H. influenzae by visiting the
following Web site:
http://www.cdc.gov/ncidod/dbmd/diseaseinfo/haeminfluserob_t.htm
Back to Table of Contents
[an error occurred while processing this directive]